Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorRWTH Aachen University
About this trial
The study investigates the adjuvant SBRT following TACE in early and intermediate stages HCC not amenable for surgical resection.
Eligibility criteria
Qualifiers
HCC (diagnosis: histological or radiological)
Age: 18-80
Number of lesions 1-3 lesions
Size of the lesion (or sum of 2-3 lesions) ≥ 4 cm
Disqualifiers
Evidence of extrahepatic disease (lymph node or distant metastases)
Evidence of macroscopic vascular invasion
Evidence of an arterio-portal or arterio-venous fistulas
History of previous malignancy
Trial design
Treatments tested in this trial
- TACE
- SBRT
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov